Drug Shortage Report for BETASERON

Last updated on 2022-06-10 History
Report ID 162399
Drug Identification Number 02169649
Brand name BETASERON
Common or Proper name INTERFERON BETA-1B
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) INTERFERON BETA-1B
Strength(s) 0.3MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 15 Single Use Pack
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-07-01
Actual start date
Estimated end date 2022-07-05
Actual end date
Shortage status Anticipated shortage
Updated date 2022-06-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-06-10 French Compare
v1 2022-06-10 English Compare

Showing 1 to 2 of 2